WO2025017368 - METHODS FOR TREATING CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
National phase entry:
Publication Number
WO/2025/017368
Publication Date
23.01.2025
International Application No.
PCT/IB2024/000374
International Filing Date
16.07.2024
Title **
[English]
METHODS FOR TREATING CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
[French]
MÉTHODES DE TRAITEMENT D'UNE POLYNEUROPATHIE DÉMYÉLINISANTE INFLAMMATOIRE CHRONIQUE
Applicants **
ARGENX BV
Inventors
HOFMAN, Erik
PARYS, Wim
BEELKE, Manolo
DINCQ, Stephanie
LOWE, Murray
SEGHERS, Katarina
DE PAEPE, Els
VAN HOORICK, Benjamin
ISTAS, Geoffrey
JIANG, Ming
GUPTILL, Jeffrey
BEAUCHAMP, Jon
TRUYEN, Luc
Priority Data
2310890.5
16.07.2023
GB
63/617,702
04.01.2024
US
63/662,098
20.06.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 8400 | |
| EPO | Filing, Examination, Granting | 228451 | |
| Japan | Filing, Examination, Granting | 5432 | |
| South Korea | Filing, Examination, Granting | 13231 | |
| USA | Filing, Examination, Granting | 47890 |
Total:
303,404
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to methods of treating Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) using an antagonist of human neonatal Fc receptor (FcRn), which in certain embodiments is efgartigimod.[French]
La présente invention concerne des méthodes de traitement de la polyneuropathie démyélinisante inflammatoire chronique (PDIC) à l'aide d'un antagoniste du récepteur Fc néonatal (FcRn) humain, qui dans certains modes de réalisation est l'efgartigimod.